10x Genomics, Inc. (TXG) Operating cash flow 2017–2025
10x Genomics, Inc. (TXG) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$136.1MFY2025 · since FY2017: -$10.7M → $136.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $136.1M | +1941.6% |
| FY2024 | $6.7M | +143.9% |
| FY2023 | -$15.2M | +54.8% |
| FY2022 | -$33.6M | -57.2% |
| FY2021 | -$21.4M | +90.2% |
| FY2020 | -$217.9M | -729.3% |
| FY2019 | $34.6M | +145.3% |
| FY2018 | -$76.4M | -614.2% |
| FY2017 | -$10.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice